NO954079L - Fremstilling av matrikser - Google Patents

Fremstilling av matrikser

Info

Publication number
NO954079L
NO954079L NO954079A NO954079A NO954079L NO 954079 L NO954079 L NO 954079L NO 954079 A NO954079 A NO 954079A NO 954079 A NO954079 A NO 954079A NO 954079 L NO954079 L NO 954079L
Authority
NO
Norway
Prior art keywords
pct
cellulose
matrices
date oct
sec
Prior art date
Application number
NO954079A
Other languages
English (en)
Other versions
NO312085B1 (no
NO954079D0 (no
Inventor
Seth Bjork
Ragnar Ek
Gert Ragnarsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO954079D0 publication Critical patent/NO954079D0/no
Publication of NO954079L publication Critical patent/NO954079L/no
Publication of NO312085B1 publication Critical patent/NO312085B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02Cellulose; Modified cellulose
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00Foams characterised by the foaming process
    • C08J2201/04Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/05Elimination by evaporation or heat degradation of a liquid phase
    • C08J2201/0504Elimination by evaporation or heat degradation of a liquid phase the liquid phase being aqueous
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/02Cellulose; Modified cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Insulating Materials (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymerisation Methods In General (AREA)
  • Glass Compositions (AREA)
  • Vending Machines For Individual Products (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19954079A 1993-04-14 1995-10-13 Fremgangsmåte for fremstilling av poröse cellulosematrikser og tabletter, samt multippelenhetspreparat og tablett inneholdendecellulosematriksene NO312085B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939301220A SE9301220D0 (sv) 1993-04-14 1993-04-14 Manufacturing matrices
PCT/SE1994/000331 WO1994023703A1 (en) 1993-04-14 1994-04-14 Manufacturing matrices

Publications (3)

Publication Number Publication Date
NO954079D0 NO954079D0 (no) 1995-10-13
NO954079L true NO954079L (no) 1995-10-13
NO312085B1 NO312085B1 (no) 2002-03-18

Family

ID=20389559

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19954079A NO312085B1 (no) 1993-04-14 1995-10-13 Fremgangsmåte for fremstilling av poröse cellulosematrikser og tabletter, samt multippelenhetspreparat og tablett inneholdendecellulosematriksene

Country Status (16)

Country Link
US (1) US5804217A (no)
EP (1) EP0695173B1 (no)
JP (1) JP3385369B2 (no)
AT (1) ATE189120T1 (no)
AU (1) AU680494B2 (no)
CA (1) CA2159908C (no)
DE (1) DE69422806T2 (no)
DK (1) DK0695173T3 (no)
ES (1) ES2144517T3 (no)
FI (1) FI115442B (no)
GR (1) GR3033274T3 (no)
NO (1) NO312085B1 (no)
NZ (1) NZ265131A (no)
PT (1) PT695173E (no)
SE (1) SE9301220D0 (no)
WO (1) WO1994023703A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2271652A1 (en) * 1996-11-12 1998-05-22 Pharmacia & Upjohn Ab Compact member comprising a plurality of porous cellulose matrices, (pcms), method of manufacturing and use thereof
EP0955332B1 (en) 1997-01-07 2006-07-19 Kaneka Corporation Adsorbent for body fluid purification
DE69940557D1 (de) 1998-12-11 2009-04-23 Nostrum Pharmaceuticals Inc Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
US6572887B2 (en) * 2000-05-01 2003-06-03 National Starch And Chemical Investment Holding Corporation Polysaccharide material for direct compression
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
JP5240822B2 (ja) * 2005-04-22 2013-07-17 旭化成ケミカルズ株式会社 多孔質セルロース凝集体及びその成型体組成物
JP5439366B2 (ja) 2008-05-21 2014-03-12 旭化成ケミカルズ株式会社 偏析防止効果に優れるセルロース粉末及びその組成物
ES2796835T3 (es) * 2013-03-13 2020-11-30 Intervet Int Bv Sustancias bioactivas estables y métodos de fabricación
JP6522396B2 (ja) * 2015-04-02 2019-05-29 北越コーポレーション株式会社 セルロース多孔質体の製造方法
AU2019101024A4 (en) * 2018-12-24 2019-10-10 Thomas W Railsback Improved cooling apparatus

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286829A (no) * 1961-12-29
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
CS172640B1 (no) * 1974-05-30 1977-01-28
US4063017A (en) * 1976-04-22 1977-12-13 Purdue Research Foundation Porous cellulose beads and the immobilization of enzymes therewith
SE434848B (sv) * 1976-04-22 1984-08-20 Purdue Research Foundation Forfaringssett for framstellning av porosa cellulosaperlor
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4269859A (en) * 1979-04-19 1981-05-26 Brown Company Cellulose floc granules and process
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4464224A (en) * 1982-06-30 1984-08-07 Cip Inc. Process for manufacture of high bulk paper
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JPS6443530A (en) * 1987-08-10 1989-02-15 Asahi Chemical Ind Porous cellulose particle and its production
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
US4806360A (en) * 1987-10-23 1989-02-21 Advanced Polymer Systems Synthetic melanin aggregates
SE9002017D0 (sv) * 1990-06-06 1990-06-06 Kabivitrum Ab Process for manufacture of matrices
ATE104826T1 (de) * 1990-07-02 1994-05-15 Bend Res Inc Asymmetrische mikroporoese kuegelchen fuer regulierbare freigabe.
DK0472502T3 (da) * 1990-08-24 1995-10-09 Spirig Ag Fremgangsmåde til fremstilling af pellets
NZ239802A (en) * 1990-09-21 1993-09-27 Merrell Dow Pharma A superior tasting pharmaceutical composition having porous particles produced through in situ gas generation and a process for its production
US5223090A (en) * 1991-03-06 1993-06-29 The United States Of America As Represented By The Secretary Of Agriculture Method for fiber loading a chemical compound
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형

Also Published As

Publication number Publication date
FI954883L (fi) 1995-10-13
FI115442B (fi) 2005-05-13
ATE189120T1 (de) 2000-02-15
JP3385369B2 (ja) 2003-03-10
SE9301220D0 (sv) 1993-04-14
AU6547394A (en) 1994-11-08
CA2159908C (en) 2003-12-30
DK0695173T3 (da) 2000-07-10
NO312085B1 (no) 2002-03-18
WO1994023703A1 (en) 1994-10-27
PT695173E (pt) 2000-07-31
ES2144517T3 (es) 2000-06-16
FI954883A0 (fi) 1995-10-13
DE69422806D1 (de) 2000-03-02
GR3033274T3 (en) 2000-09-29
NZ265131A (en) 1998-05-27
US5804217A (en) 1998-09-08
EP0695173B1 (en) 2000-01-26
CA2159908A1 (en) 1994-10-27
AU680494B2 (en) 1997-07-31
NO954079D0 (no) 1995-10-13
DE69422806T2 (de) 2000-08-17
JPH08510766A (ja) 1996-11-12
EP0695173A1 (en) 1996-02-07

Similar Documents

Publication Publication Date Title
AU3269993A (en) An implant
DK0532611T3 (da) Fremgangsmåde til fremstilling af porøse cellulosematrixer
NO954079D0 (no) Fremstilling av matrikser
ATE152573T1 (de) Protein mit zeitverabreichung
GR3030706T3 (en) Slow release formulation
SE8102292L (sv) Forfarande for framstellning av en mikroporos strukturerad loslig kaffeprodukt
CA2016297A1 (en) Device and method for depletion of the leucocyte content of blood and blood components
AU8050791A (en) Compositions and methods for the controlled release of soluble active substances
DK164256C (da) Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf
ES8707759A1 (es) Un procedimiento para manufacturar un ingrediente antiespumante particulado
TR27802A (tr) Kendinden dayanikli, gecirgen olacak sekilde gözenekli plastik sekilli gövdeye sahip bir filtre elemani.
AU567968B2 (en) Device for controlled release of active ingredients
AU3102597A (en) Method for providing dense particle compositions for use in transdermal particle delivery
DE3279437D1 (en) Method for extracting propolis and water soluble dry propolis powder obtained thereby and cosmetic and pharmaceutical preparations containing same
WO1996015660A3 (de) Implantierbare vorrichtung zur verabreichung von wirkstoffen an pflanzen
HUT44412A (en) Fungicides comprising trisubstituted 1,3,5-triazine-2,4,6-trione derivatives as active substance and process for preparing the active substances
CA2080836A1 (en) Solid-form additive systems dispersible in aqueous media, methods for the preparation and application thereof to polymeric particles
JPS6471822A (en) Ophthalmic sustained release preparation
JPS6429438A (en) Polyvinyl alcohol film
JPS5596095A (en) Composite particle group containing active protein substance * production * use and regeneration thereof
RU2001117522A (ru) Способ получения лекарственных средств из растительных экстрактов в твердой форме
GR3003872T3 (no)
JPS5659707A (en) Lasting antibiotic pharmaceutical and its preparation
JPS5437880A (en) Preparation of yeast cells having improved taste and dispersibility
JPS57106610A (en) Preparation of prolonged release type composite